Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients - 02/06/17
, Guanglong Dong 7, ⁎ Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 8 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Background |
POLG is a gene that codes for the catalytic subunit of the mitochondrial DNA polymerase, which is involved in the replication of mitochondrial DNA. Genetic variants in mitochondrial DNA polymerase-γ (POLG) have been associated with several malignancies. However, as an important metabolic tissue, association between genetic polymorphisms of POLG and the prognosis and mitochondrial DNA (mtDNA) content in hepatocellular carcinoma (HCC) remains unknown. Here we investigated the association between in POLG with the prognosis and mitochondrial DNA (mtDNA) content in hepatocellular carcinoma (HCC).
Methods |
Three nucleotide polymorphisms (SNPs) of rs1061316, rs2247233 and rs758130 in POLG were examined in 416 patients from two cohorts undergoing transcatheter arterial chemoembolization treatment. Leukocyte mtDNA content from 216 patients in cohort 2 was measured using a real-time PCR-based method. The association of SNPs with prognosis and of mtDNA content of patients was analyzed.
Results |
The rs758130 in POLG gene was significantly associated with the prognosis of patients in a dose-dependent manner. Moreover, GG genotype in rs1061316 showed significantly high mtDNA content, an indicator of better prognosis.
Conclusions |
Our study for the first time demonstrates that rs1061316 and rs758130 in POLG is associated with the prognosis and leukocyte mtDNA content in HCC patients.
Le texte complet de cet article est disponible en PDF.Keywords : Mitochondrial DNA ploymerase-γ, Single nucleotide polymorphism, Hepatocellular carcinoma, Prognosis, Mitochondrial DNA content
Plan
Vol 104 - N° 6
P. 500-507 - juin 2017 Retour au numéro
Article précédent
- La controverse des médicaments génériques en oncologie
- Dominique Levêque, Guillaume Becker, Bénédicte Gourieux
- Reconstruction mammaire chez les patientes âgées : études des pratiques de l’institut Bergonié 2005–2015
- Guillaume Babin, Julie Commeny, Marion Fournier, Aurélien Rousvoal, Youssef Kabbani, Marc Debled, Anne Jaffre, Christine Tunon de Lara
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?